Tilray Brands, Inc.

TSX:TLRY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.23 -1.19%

-$0.08 today

Market cap
$477.35M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $0.49High $21.57

Volume 0.86M

Average 0.64M

TLRY.TO Interest Expense

Cost of servicing the company's debt during the period.

Tilray Brands, Inc.TSX: TLRY.TO

Interest Expense · Q3 FY2026 · quarter ended Feb 2026

Interest expense declines year over year

Q3 FY2026 interest expense of $4.97M fell 40.7% year over year, behind the -34.7% change in trailing-twelve-month interest expense. Sequentially, it fell 33.9% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.

Context

  • Interest expense amounted to 5.0% of revenue in FY2025, down 1.2 pp from a year earlier.
  • Interest expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -40.7% toward the trailing-twelve-month pace of -34.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$4.97M-33.9% QoQ
Last fiscal yearMay 2025
$41.33M-16.1% YoY
LTMFeb 2026
$23.15M-34.7% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-40.7%——
1 year-16.1%——
3-year CAGR+1.4%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
41.33M USD
Year-over-year change
-16.1%
4-year CAGR
+7.5%

Interest Expense vs competitors

How TLRY.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -34.7% is the lowest of 3, against a peer median of -27.9%.
  • Interest expense amounts to 2.7% of revenue for TLRY.TO, versus a peer median of 1.2%.
TLRY.TO Competitors
Interest Expense for TLRY.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRY.TOTilray Brands, Inc.LTM Feb 2026$23.15M USD-34.7%+1.4%2.7%
ACBAurora Cannabis Inc.LTM Mar 2026CA$5.82M CAD-30.9%-64.2%1.9%
SNDLSNDL Inc.LTM Mar 2026CA$5.69M CAD-24.9%+8.4%0.6%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY.TO) —-27.9%-27.9%1.2%

Competitors are the stored peer set for TLRY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue513.09M628.37M630.88M788.94M821.31M
Cost of Revenue389.9M511.56M480.16M565.59M580.74M
Gross Profit123.18M116.82M146.96M223.35M240.57M
Gross Margin24.0%18.6%23.3%28.3%29.3%
Research & Development830K1.52M686.09K635K284K
Selling, General & Admin155.69M228.66M232.32M250.72M259.48M
Operating Expenses255.35M215.66M1.04B398.1M2.52B
Depreciation & Amortization67.83M154.59M130.15M126.91M133.49M
EBITDA(246.25M)(246.4M)(1.27B)(72.84M)(2.13B)
EBITDA Margin-48.0%-39.2%-201.8%-9.2%-259.0%
Operating Income(68.55M)(98.85M)(185.85M)(174.75M)(2.28B)
Operating Margin-13.4%-15.7%-29.5%-22.1%-277.9%
Interest Income2.93M11.74M33.03M12.83M11.38M
Interest Expense30.9M39.68M13.59M49.26M41.33M
Other Income / Expenses(212.82M)(341.83M)(1.27B)(74.28M)(19.67M)
Income Before Tax(344.99M)(440.67M)(1.46B)(249.02M)(2.3B)
Pre-Tax Margin-67.2%-70.1%-231.3%-31.6%-280.3%
Income Tax Expense(8.97M)(6.54M)(7.18M)(26.62M)(121.02M)
Net Income(367.42M)(440.67M)(1.44B)(244.98M)(2.19B)
Net Margin-71.6%-70.1%-228.7%-31.1%-266.3%
EPS (Basic)(13.63)(9.95)(23.40)(3.30)(24.10)
EPS (Diluted)(13.63)(9.95)(23.40)(3.30)(24.10)
Weighted Avg Shares26.95M48.12M61.8M74.26M90.83M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M90.83M

Tilray Brands, Inc.

TSX:TLRY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.